C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1999
11/03/1999	EP0953054A1 Ehv-1 vectors
11/03/1999	EP0953053A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/03/1999	EP0953041A1 Serum-free mammalian cell culture medium, and uses thereof
11/03/1999	CN1234075A Retroviral vector
11/02/1999	US5977438 Production of peptides in plants as viral coat protein fusions
11/02/1999	US5976861 Proteins for the isolation of antibodies.
11/02/1999	US5976787 Possible sites for gene inactivation to attenuate mdv field isolates for vaccine purposes.
11/02/1999	US5976785 Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
11/02/1999	US5976537 A previously unknown disease of pigs, prrs was recognized for the first time in the united states in north carolina in 1987. from there, it quickly spread throughout all of the major swine producing areas of north america.
10/1999
10/28/1999	WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999	WO1999054441A1 Efficient purification of adenovirus
10/28/1999	WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999	WO1999053959A2 Use of viral vectors for treatment of the injured peripheral and central nervous system
10/28/1999	WO1999005272A9 Use of transcription factor brn-3a
10/28/1999	CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/27/1999	EP0952214A1 Aviadenovirus
10/27/1999	EP0951559A1 Recombinant pox virus for immunization against tumor-associated antigens
10/27/1999	CN1232704A Culture process of high-yield weak-toxicity distemper cell strain
10/27/1999	CN1045994C Modification of plant viruses or their effects
10/26/1999	US5972706 Recombinant cytopathic viruses which are capable of replication and/or expression of late region genes in neoplastic mammalian cells but are essentially non-replicable in non-neoplastic cells, methods for constructing and
10/26/1999	US5972666 Assembly-deficient herpesvirus vaccine
10/26/1999	US5972650 Can be used as vehicles for the delivery of nucleic acids that can serve as therapeutic agents and as part of vaccines designed to immunize people or animals against viral diseases.
10/26/1999	US5972597 Methods using modified vaccinia virus
10/21/1999	WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999	WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999	WO1999052545A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/21/1999	CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999	CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999	CA2294018A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/20/1999	EP0950111A1 Methods using cre-lox for production of recombinant adeno-associated viruses
10/20/1999	EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999	EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999	EP0950091A2 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
10/20/1999	CN1232504A 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of order designated mononegavirales
10/19/1999	US5969108 Methods for producing members of specific binding pairs
10/19/1999	US5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor
10/19/1999	US5968522 Dna and antibiodies directed against polypeptides
10/14/1999	WO1999051781A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999	WO1999051749A2 Recombinant potyvirus construct and use thereof
10/14/1999	WO1999051721A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
10/14/1999	WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999	WO1999051263A2 Methods and modified cells for the treatment of cancer
10/14/1999	WO1999041399A9 Methods for purified aav vector production
10/14/1999	CA2327445A1 Recombinant potyvirus construct and use thereof
10/14/1999	CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/13/1999	EP0948637A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
10/13/1999	EP0948601A1 Methods for purifying viruses
10/13/1999	EP0948600A2 Nanoscale particles synthesized within an assembled virion
10/13/1999	EP0948351A1 Synthetic hpv16 virus-like particles
10/13/1999	EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
10/13/1999	EP0672192B1 Method for inhibition of viral morphogenesis
10/12/1999	US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999	US5965358 Providing an aliquot, producing charged fragments from the aliquot, detecting fragments by a detector which produces a signal corresponding to the mass-to-charge ratio of the detected fragments, evaluating purity using a standard signal
10/12/1999	US5965138 Recombinant chimeric virus and vaccine comprising a long viral genomic region from the herpes virus of turkeys and a short viral genomic region from marek's disease virus; immunizing birds
10/12/1999	US5965135 HIV-1 virus isolates of a subtype and its differential diagnostics
10/12/1999	US5965123 Coated pesticidal agents, processes for their preparation and compositions containing them
10/07/1999	WO1999050432A1 Inducible alphaviral gene expression system
10/07/1999	WO1999050424A2 Fusion protein comprising a sequence from a major coat protein of a papovavirus
10/07/1999	WO1999050419A2 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
10/07/1999	WO1999050416A1 Tnf-related death ligand
10/07/1999	WO1999050292A1 Recombinant virus
10/07/1999	WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999	WO1999031251A9 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/07/1999	CA2325564A1 Inducible alphaviral gene expression system
10/07/1999	CA2324441A1 Materials and methods relating to a novel retrovirus
10/06/1999	EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999	EP0946741A1 Method for producing recombinant virus
10/06/1999	EP0946740A1 Novel constructs and vectors for the targeted and inducible expression of genes
10/06/1999	EP0946731A1 Non-m non-o hiv strains, fragments and applications
10/06/1999	EP0946723A1 Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
10/06/1999	EP0946714A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
10/06/1999	EP0946193A1 Stabilizers for lyophilized vaccines
10/06/1999	CN1230893A Assembly-deficient herpesvirus vaccine
10/05/1999	US5962635 Therapeutic compounds
10/05/1999	US5962313 Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
10/05/1999	US5962311 A method of targeting attachment of a short-shafted recombinant adenovirus to a cell so as to effect entry of the short-shafted recombinant adenovirus into the cell.
10/05/1999	US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
10/05/1999	US5961982 Recombinant herpesvirus of turkeys and uses thereof
10/05/1999	CA1340779C Plasmids causing densunucleosis; process for preparing the same and their use for the biological control of insect pests
09/1999
09/30/1999	WO1999049017A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
09/30/1999	WO1999031261A9 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS
09/30/1999	CA2323927A1 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
09/29/1999	EP0945463A2 Process for the preparation of human leukocyte (alpha) interferon
09/29/1999	EP0944717A1 Method for producing recombinant adenovirus
09/29/1999	EP0714307B1 Vaccine compositions
09/29/1999	EP0591281B1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
09/29/1999	CN1230197A Subunit respiratory syncytial virus vaccine prepn.
09/28/1999	US5959093 The present invention relates to novel genes of new field isolates of bovine rotavirus which permit the genotyping and thus the diagnosis of such new strains.
09/28/1999	US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
09/28/1999	US5958425 Viral vaccines
09/28/1999	US5958424 Recombinant chicken anemia virus particle
09/28/1999	US5958422 Containing a foreign peptide insert in the coat protein of the virus; for use in vaccines
09/23/1999	WO1999047691A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
09/23/1999	WO1999047660A1 Retroviral packaging cell line
09/23/1999	WO1999047659A1 Use of human serum resistant vector particles and cell lines for human gene therapy
09/23/1999	WO1999047653A1 Suicide gene therapy system for the treatment of brain tumours
09/23/1999	WO1999047648A2 Medium and method for viral propagation and growth
09/23/1999	WO1999047645A1 Process for the production of virus in cell cultures
09/23/1999	WO1999038955A3 Mutant herpes simplex viruses and uses thereof
09/23/1999	CA2604824A1 Retroviral packaging cell line

1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 267